IGF2 and breast carcinoma: Considering that hypoxia promotes HIF-1α-mediated transcription and secretion of IGF-II [227], it is perhaps unsurprising that HIF-1α inhibitors decrease IGF-II signaling and trigger anti-migratory effects in breast cancer cells [228].